Patents by Inventor Jerzy Golik

Jerzy Golik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6455575
    Abstract: The present invention concerns antitumor compounds. More particularly, the invention provides novel taxane derivatives, pharmaceutical compositions thereof, and their use as antitumor agents.
    Type: Grant
    Filed: June 6, 1997
    Date of Patent: September 24, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jerzy Golik, Dolatrai Vyas, John J. Wright, Henry Wong, John F. Kadow, John K. Thottathil, Wen-Sen Li, Murray A. Kaplan, Robert K. Perrone, Mark D. Wittman
  • Patent number: 6362172
    Abstract: Water-soluble prodrugs of triazole antifungal compounds having a secondary or tertiary hydroxy group are provided. More particularly, new water-soluble triazole antifungal compounds are provided having the general formula wherein A is the non-hydroxy portion of a triazole antifungal compound of the type containing a secondary or tertiary hydroxyl group and R and R1 are as defined in the specification.
    Type: Grant
    Filed: January 10, 2001
    Date of Patent: March 26, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventors: Yasutsugu Ueda, John D. Matiskella, Jerzy Golik, Thomas W. Hudyma, Chung-Pin Chen
  • Publication number: 20010041691
    Abstract: Water-soluble prodrugs of triazole antifungal compounds having a secondary or tertiary hydroxy group are provided.
    Type: Application
    Filed: January 10, 2001
    Publication date: November 15, 2001
    Inventors: Yasutsugu Ueda, John D. Matiskella, Jerzy Golik, Thomas W. Hudyma, Chung-Pin Chen
  • Publication number: 20010023255
    Abstract: The present invention concerns antitumor compounds. More particularly, the invention provides novel taxane derivatives, pharmaceutical compositions thereof, and their use as antitumor agents.
    Type: Application
    Filed: June 6, 1997
    Publication date: September 20, 2001
    Inventors: JERZY GOLIK, DOLATRAI VYAS, JOHN J. WRIGHT, HENRY WONG, JOHN F. KADOW, JOHN K. THOTTATHIL, WEN-SEN LI, MURRAY A. KAPLAN, ROBERT K. PERRONE, MARK D. WITTMAN
  • Publication number: 20010016662
    Abstract: Water soluble prodrugs of azole antifungal agents are provided by quaternizing a nitrogen atom of the azole ring with a phosphonooxymethyl group.
    Type: Application
    Filed: December 4, 2000
    Publication date: August 23, 2001
    Inventors: Jerzy Golik, John D. Matiskella, Yasutsugu Ueda
  • Publication number: 20010014742
    Abstract: Water soluble prodrugs of azole antifungal agents are provided by quaternizing a nitrogen atom of the azole ring with a phosphonooxymethyl group.
    Type: Application
    Filed: December 4, 2000
    Publication date: August 16, 2001
    Inventors: Jerzy Golik, John D. Matiskella, Yasutsugu Ueda
  • Patent number: 6235728
    Abstract: Water soluble prodrugs of azole antifungal agents are provided by quaternizing a nitrogen atom of the azole ring with a phosphonooxymethyl group.
    Type: Grant
    Filed: February 11, 2000
    Date of Patent: May 22, 2001
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jerzy Golik, John D. Matiskella, Yasutsugu Ueda
  • Patent number: 5902822
    Abstract: The present invention concerns novel paclitaxel derivatives, their use as antitumor agents, and pharmaceutical formulations.
    Type: Grant
    Filed: February 18, 1998
    Date of Patent: May 11, 1999
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jerzy Golik, Dolatrai M. Vyas
  • Patent number: 5646176
    Abstract: The present invention concerns antitumor compounds. More particularly, the invention provides novel taxane derivatives, pharmaceutical compositions thereof, and their use as antitumor agents.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: July 8, 1997
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jerzy Golik, Dolatrai Vyas, John J. Wright, Henry Wong, John F. Kadow, John K. Thottathil, Wen-Sen Li, Murray A. Kaplan, Robert K. Perrone, Mark D. Wittman
  • Patent number: 5086045
    Abstract: An antitumor antibiotic designated BMY-41339 is produced by fermentation of certain strains of Actinomadura verrucosospora. BMY-41339 exhibits antimicrobial activity and also inhibits the growth of tumors in experimental animals.
    Type: Grant
    Filed: August 24, 1990
    Date of Patent: February 4, 1992
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jerzy Golik, John Beutler, Pat Clark, John Ross, John Roach, Gary Muschik, William B. Lebherz, III
  • Patent number: 5028536
    Abstract: An antitumor antibiotic designated BMY-41339 is produced by fermentation of certain strains of Actinomadura verrucosospora. BMY-41339 exhibits antimicrobial activity and also inhibits the growth of tumors in experimental animals.
    Type: Grant
    Filed: March 15, 1989
    Date of Patent: July 2, 1991
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jerzy Golik, John Beutler, Pat Clark, John Ross, John Roach, Gary Muschik, William B. Lebherz, III
  • Patent number: 4921700
    Abstract: There is provided new antitumor antibiotic substances designated herein as BBM-1675C and BBM-1675D, said substances being produced by selective chemical hydrolysis of the bioactive components BBM-1675A.sub.1 (esperamicin A.sub.1) or BBM-1675A.sub.2 (esperamicin A.sub.2). The new antitumor antibiotics exhibit both antimicrobial activity and antitumor activity.
    Type: Grant
    Filed: May 28, 1987
    Date of Patent: May 1, 1990
    Assignee: Bristol-Myers Company
    Inventor: Jerzy Golik
  • Patent number: 4837206
    Abstract: Novel N-acetyl derivatives designated N-acetyl-esperamicins A.sub.1, A.sub.2 and A.sub.1b are prepared by acetylating known antitumor antibiotics. The new derivatives exhibit both antimicrobial and antitumor activity and have the structures ##STR1## wherein R.sup.1 and R.sup.2 are hydrogen or ##STR2## and R.sup.3 is --CH(CH.sub.3).sub.2 or --CH.sub.2 CH.sub.3.
    Type: Grant
    Filed: April 29, 1987
    Date of Patent: June 6, 1989
    Assignee: Bristol-Myers Company
    Inventor: Jerzy Golik
  • Patent number: 4743594
    Abstract: Actinomadura melliaura nov. sp. (ATCC 39691) produces four novel compounds which we have designated AT 2433 A.sub.1, AT 2433 A.sub.2, AT 2433 B.sub.1 and AT 2433 B.sub.2. The novel compounds or pharmaceutically acceptable salts thereof exhibit antibacterial and antitumor activity.
    Type: Grant
    Filed: September 17, 1984
    Date of Patent: May 10, 1988
    Assignee: Schering Corporation
    Inventors: Ann C. Horan, Jerzy Golik, James A. Matson, Mahesh G. Patel
  • Patent number: 4294958
    Abstract: Inorganic salts of trimethylammonium derivatives of polyene macrolides, particularly the inorganic salts of methyl esters of these derivatives having the general formula: ##STR1## wherein R is the residue of a polyene macrolide and X is an anion of a salt selected from the group consisting of methylsulphate, sulphate, chloride, phosphate and acetate.The preparation of salts of formula (I) or formula (II) is also disclosed.
    Type: Grant
    Filed: July 25, 1979
    Date of Patent: October 13, 1981
    Assignee: Politechnika Gdanska
    Inventors: Leonard Falkowski, Barbara Stefanska, Jan Zielinski, Elzbieta Troka, Jerzy Golik, Pawel Kolodziejczyk, Andrzej Jarzebski, Emilia Cybulska, Edward Borowski
  • Patent number: 4195172
    Abstract: The new compounds, N-methylglucamine salts of N-glycosyl derivatives of polyene macrolides particularly N-methylglucamine salts of N-glycosyl derivatives of amphotericin B, polifungin and nystatin are described herein. These compounds exhibit high pharamacological activity in some topical and sistemic fungal infections. The product is prepared by reaction of an amino group containing polyene macrolide with an aldose or ketose mono- or oligosaccharide, in an organic solvent medium or in the mixture of solvents characterized in that the formed N-glycosyl derivatives is precipitated from the reaction medium by water or with an aqueous solution of inorganic salt, preferably ammonium sulphate, and after crystallization from a higher alkanol of C.sub.3-6 atoms, preferably n-butanol transformed into a salt, preferably an N-methylglucamine salt and then crystallized from higher alkanol, preferably n-butanol.
    Type: Grant
    Filed: May 10, 1978
    Date of Patent: March 25, 1980
    Assignees: Politechnika Gdanska, Instytut Przemyslu Farmaceutycznego
    Inventors: Leonard Falkowski, Zuzanna Kowszyk-Gindifer, Zofia Plociennik, Jan Zielinski, Halina Dahlig, Jerzy Golik, Ewa Jakobs, Pawel Kolodziejczyk, Elzbieta Bylec, Danuta Roslik-Kaminska, Wladyslawa Wagner, Jan Pawlak, Edward Borowski
  • Patent number: 4093796
    Abstract: A new class of polyene macrolide antibiotics which exhibit valuable therapeutic properties are obtained by reaction of said antibiotics containing at least one amino group with mono- or oligosaccharides, and/or their derivatives in a suitable solvent.A series of such have been obtained and examined. They all exhibit a high biological activity and form salts which are soluble in water.Said sugar derivatives of antibiotics can be used as antifungal agents, also as substances to reduce the overgrowth of the prostrate gland and cholesterol level in the blood.
    Type: Grant
    Filed: August 10, 1972
    Date of Patent: June 6, 1978
    Assignee: Politechnika Gdanska
    Inventors: Leonard Falkowski, Miroslaw Bobrowski, Helena Buluk, Elzbieta Bylec, Barbara Cybulska, Jerzy Golik, Pawel Kolodziejczyk, Jan Pawlak, Andrzej Rudowski, Jan Zielinski, Tadeusz Ziminski, Edward Borowski